β-Catenin-Driven Cancers Require a YAP1 Transcriptional Complex for Survival and Tumorigenesis

Rosenbluh, Joseph, Nijhawan, Deepak, Cox, Andrew G., Li, Xingnan, Neal, James T., Schafer, Eric J., Zack, Travis I., Wang, Xiaoxing +13 more·2012·Cell

Cited by (759)

Items 201–300 of 759

  1. WNK Kinases in Development and Disease
    Aylin R. Rodan, Andreas Jenny · 2016 · Current topics in developmental biology/Current Topics in Developmental Biology
  2. Platelet‐derived growth factor regulates YAP transcriptional activity via Src family kinase dependent tyrosine phosphorylation
    Rory L. Smoot, Nathan W. Werneburg, Takaaki Sugihara, Matthew C. Hernandez, Lin Yang, Christine Mehner, Rondell Patrell Graham, Steven F. Bronk, Mark Joseph Truty, Gregory James Gores · 2017 · Journal of Cellular Biochemistry
  3. Dual inhibition of Wnt and Yes‐associated protein signaling retards the growth of triple‐negative breast cancer in both mesenchymal and epithelial states
    Andrew Sulaiman, Sarah McGarry, Li Li, Deyong Jia, Sarah Ooi, Christina Addison, Jim Dimitroulakos, Angel Arnaout, Carolyn Nessim, Zemin Yao et al. · 2018 · Molecular Oncology
  4. The Roles of Hippo Signaling Transducers Yap and Taz in Chromatin Remodeling
    Ryan E. Hillmer, Brian A. Link · 2019 · Cells
  5. Genome-scale CRISPR-Cas9 screen of Wnt/β-catenin signaling identifies therapeutic targets for colorectal cancer
    Chunhua Wan, Sylvia Mahara, Claire Xin Sun, Anh Doan, Hui Kheng Chua, Dakang Xu, Jia Bian, Yue Li, Danxi Zhu, Dhanya Sooraj et al. · 2021 · Science Advances
  6. Nerves in gastrointestinal cancer: from mechanism to modulations
    Nathalie Vaes, Musa Idris, Werend Boesmans, Maria M. Alves, Veerle Melotte · 2022 · Nature Reviews Gastroenterology & Hepatology
  7. Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers
    Joseph Rosenbluh, Johnathan Mercer, Yashaswi Shrestha, Rachel Oliver, Pablo Tamayo, John G. Doench, Itay Tirosh, Federica Piccioni, Ella Hartenian, Heiko Horn et al. · 2016 · Cell Systems
  8. Mechanosensation to inflammation: Roles for YAP/TAZ in innate immune cells
    Vijaykumar S. Meli, Praveen Krishna Veerasubramanian, Timothy L. Downing, Wenqi Wang, Wendy F. Liu · 2023 · Science Signaling
  9. Hippo pathway and breast cancer stem cells
    Marcello Maugeri‐Saccà, Ruggero D. Maria · 2015 · Critical Reviews in Oncology/Hematology
  10. IL‐6/YAP1/β‐catenin signaling is involved in intervertebral disc degeneration
    Jian Chen, Zheng-Feng Mei, Bao Hua Huang, Xuyang Zhang, Junhui Liu, Zhi Shan, Jiasheng Wang, Xianjun Wang, Fengdong Zhao · 2018 · Journal of Cellular Physiology
  11. The Hippo pathway in disease and therapy: cancer and beyond
    Marta Gómez-Ferrer, Valentí Gómez, Alexander Hergovich · 2014 · Clinical and Translational Medicine
  12. Cis-regulatory architecture of a brain signaling center predates the origin of chordates
    Yao Yao, Paul J Minor, Ying-Tao Zhao, Yongsu Jeong, Ariel M. Pani, Anna N. King, Orsolya Symmons, Lin Gan, Wellington Veras Cardoso, François Spitz et al. · 2016 · Nature Genetics
  13. Genome-wide association study identifies three susceptibility loci for laryngeal squamous cell carcinoma in the Chinese population
    Qingyi Wei, Dianke Yu, Mingbo Liu, Mengyun Wang, Miaoqing Zhao, Ming Liu, Wei‐Hua Jia, Hongxia Ma, Jugao Fang, Wei Xu et al. · 2014 · Nature Genetics
  14. T-box transcription factors in cancer biology
    Sabina Maria Wansleben, Jade Peres, Shannagh Hare, Colin R. Goding, Sharon Prince · 2014 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  15. Intracellular Signals Activated by Canonical Wnt Ligands Independent of GSK3 Inhibition and β-Catenin Stabilization
    Antonio Garcı́a de Herreros, Mireia Duñach · 2019 · Cells
  16. Collagen Kinase Receptors as Potential Therapeutic Targets in Metastatic Colon Cancer
    Marie Lafitte, Audrey Sirvent, Serge Roche · 2020 · Frontiers in Oncology
  17. ABHD5 inhibits YAP-induced c-Met overexpression and colon cancer cell stemness via suppressing YAP methylation
    Yan Jennifer Gu, Yanrong Chen, Lai Wei, Shuang Wu, Kaicheng Shen, Chengxiang Liu, Yan Dong, Zhao Yang, Yue Zhang, Chi Zhang et al. · 2021 · Nature Communications
  18. The Hippo–YAP/TAZ Signaling Pathway in Intestinal Self-Renewal and Regeneration After Injury
    Feihong Deng, Zengrong Wu, Fei Zou, Su Wang, Xuehong Wang · 2022 · Frontiers in Cell and Developmental Biology
  19. TTK Inhibitors as a Targeted Therapy for CTNNB1 ( β -catenin) Mutant Cancers
    Guido J.R. Zaman, Jeroen A.D.M. de Roos, Marion A.A. Libouban, Martine B.W. Prinsen, Jos de Man, Rogier C. Buijsman, Joost C.M. Uitdehaag · 2017 · Molecular Cancer Therapeutics
  20. New insights into the Hippo/YAP pathway in idiopathic pulmonary fibrosis
    Mingyao Sun, Yangyang Sun, Ziru Feng, Xinliang Kang, Weijie Yang, Yongan Wang, Yuan Luo · 2021 · Pharmacological Research
  21. Crosstalk between Hypoxia and Extracellular Matrix in the Tumor Microenvironment in Breast Cancer
    Yasmin Dekker, Sylvia E. Le Dévédec, Erik H.J. Danen, Qiuyu Liu · 2022 · Genes
  22. Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma
    Liyam Laraba, Lily Hillson, Julio Grimm de Guibert, Amy Hewitt, Maisie R. Jaques, Tracy Tzu-Ling Tang, Leonard E. Post, Emanuela Ercolano, Ganesha Rai, Shyh‐Ming Yang et al. · 2022 · Brain
  23. A combinatorial strategy using YAP and pan-RAF inhibitors for treating KRAS-mutant pancreatic cancer
    Xiao Zhao, Xiuchao Wang, Lijun Fang, Chungen Lan, Xiaowei Zheng, Yongwei Wang, Yinlong Zhang, Xuexiang Han, Shaoli Liu, Keman Cheng et al. · 2017 · Cancer Letters
  24. LncRNA‐CCAT5‐mediated crosstalk between Wnt/β‐Catenin and STAT3 signaling suggests novel therapeutic approaches for metastatic gastric cancer with high Wnt activity
    Chenchen Liu, Aiwen Shen, Junquan Song, Lei Cheng, Meng Zhang, Yanong Wang, Xiaowen Liu · 2023 · 癌症:英文版
  25. Yap control of tissue growth relies on cell density and F-actin in zebrafish fin regeneration
    Rita Mateus, Raquel Lourenço, Yi Fang, Gonçalo Brito, Ana Farinho, Fábio Valério, António Jacinto · 2015 · Development
  26. Inactivation of hypoxia-induced YAP by statins overcomes hypoxic resistance tosorafenib in hepatocellular carcinoma cells
    Tianyi Zhou, Linhan Zhuang, Yan Wei Hu, Yulu Zhou, Wenkai Lin, Dandan Wang, Zi-qian Wan, Lin-lin Chang, Ying Chen, Meidan Ying et al. · 2016 · Scientific Reports
  27. An integrated genomic analysis of anaplastic meningioma identifies prognostic molecular signatures
    Grace Collord, Patrick S. Tarpey, Natalja Kurbatova, Iñigo Martincorena, Sebastián Morán, Manuel Castro de Moura, Tibor Nagy, Graham R. Bignell, Francesco Maura, Matthew D. Young et al. · 2018 · Scientific Reports
  28. Hypoxia-inducible factor 2α (HIF-2α) promotes colon cancer growth by potentiating Yes-associated protein 1 (YAP1) activity
    Xiaoya Ma, Huabing Zhang, Xiang Xue, Yatrik Madhukar Shah · 2017 · Journal of Biological Chemistry
  29. Regulation of Myocardial Cell Growth and Death by the Hippo Pathway
    Shohei Ikeda, Junichi Sadoshima · 2016 · Circulation Journal
  30. PLAGL2 promotes epithelial–mesenchymal transition and mediates colorectal cancer metastasis via β-catenin-dependent regulation of ZEB1
    Liang Wu, Zili Zhou, Shengbo Han, Jinhuang Chen, Zhengyi Liu, Xudan Zhang, Wenzheng Yuan, Jintong Ji, Xiaogang Shu · 2019 · British Journal of Cancer
  31. Endogenous Retrovirus-Derived lncRNA BANCR Promotes Cardiomyocyte Migration in Humans and Non-human Primates
    Kitchener D. Wilson, Mohamed Ameen, Hong-Chao Guo, Oscar J. Abilez, Lei Tian, Maxwell R. Mumbach, Sebastian Diecke, Xulei Qin, Yonggang Liu, Hua-Xiao Yang et al. · 2020 · Developmental Cell
  32. Emerging Principles in the Transcriptional Control by YAP and TAZ
    Alejandro Lopez-Hernandez, Silvia Sberna, Stefano Campaner · 2021 · Cancers
  33. FGF8 promotes colorectal cancer growth and metastasis by activating YAP1
    Rui R Liu, Shan Huang, Yunlong Lei, Tao Zhang, Kui Wang, Bo Liu, Edouard Collins Nice, Rong Xiang, Ke Xie, Jingyi Li et al. · 2014 · Oncotarget
  34. Rho-mediated signaling promotes BRAF inhibitor resistance in de-differentiated melanoma cells
    Sean A. Misek, Kate M. Appleton, Thomas Steven Dexheimer, Erika Mathes Lisabeth, Roger S. Lo, Scott D. Larsen, Kathleen A. Gallo, Richard R. Neubig · 2019 · Oncogene
  35. c-Abl antagonizes the YAP oncogenic function
    Rom Keshet, Julia Adler, Inna Ricardo-Lax, Matan Shanzer, Ziv Porat, Nina Bacher Reuven, Yosef Shaul · 2014 · Cell Death and Differentiation
  36. MicroRNA profiling of cisplatin-resistant oral squamous cell carcinoma cell lines enriched with cancer-stem-cell-like and epithelial-mesenchymal transition-type features
    Ruma Dey Ghosh, Sangeeta Ghuwalewala, Pijush K. Das, Sapan Mandloi, Sk. Kayum Alam, Jayanta Chakraborty, Sajal Sarkar, Saikat Chakrabarti, Chinmoy Kumar Panda, Susanta Roychoudhury · 2016 · Scientific Reports
  37. The NDR/LATS protein kinases in immunology and cancer biology
    Ahmad A.D. Sharif, Alexander Hergovich · 2017 · Seminars in Cancer Biology
  38. YAP1-TEAD1 signaling controls angiogenesis and mitochondrial biogenesis through PGC1α
    Akiko Mammoto, Megan Muyleart, Andrew O. Kadlec, David D. Gutterman, Tadanori Mammoto · 2018 · Microvascular Research
  39. Correlations between TBL1XR1 and recurrence of colorectal cancer
    Hongda Liu, Yunfei Xu, Qun Zhang, Kangshuai Li, Dawei Wang, Shuo Li, Shanglei Ning, Hui Yang, Weichen Shi, Zhaochen Liu et al. · 2017 · Scientific Reports
  40. MicroRNA deregulation in nonalcoholic steatohepatitis-associated liver carcinogenesis
    Aline de Conti, Juliana Festa Ortega, Volodymyr Tryndyak, Kostiantyn Dreval, Fernando Salvador Moreno, Ivan Rusyn, Frederick A. Beland, Igor P. Pogribny · 2017 · Oncotarget
  41. YAP/TAZ-Mediated Upregulation of GAB2 Leads to Increased Sensitivity to Growth Factor–Induced Activation of the PI3K Pathway
    Chao Wang, Chao Gu, Kang Jin Jeong, Dong Zhang, Wei Guo, Yiling Lu, Zhenlin Ju, Nattapon Panupinthu, Ji Yeon Yang, Mihai Gagea et al. · 2017 · Cancer Research
  42. Transcriptional co-activators YAP/TAZ: Potential therapeutic targets for metastatic breast cancer
    Wenxia Zhao, Mengyan Wang, Meilian Cai, Cong-Hui Zhang, Yuhan Qiu, Xiaowei Wang, Tianshu Zhang, Huimin Zhou, Junxia Wang, Wuli Zhao et al. · 2020 · Biomedicine & Pharmacotherapy
  43. Synthetic Essentiality of Tryptophan 2,3-Dioxygenase 2 in APC -Mutated Colorectal Cancer
    Rumi Lee, Jiexi Li, Jun Li, Chang‐Jiun Wu, Shan Jiang, Wen-Hao Hsu, Deepavali Chakravarti, Peiwen Chen, Kyle A. LaBella, Jing Li et al. · 2022 · Cancer Discovery
  44. New Insights into YAP/TAZ-TEAD-Mediated Gene Regulation and Biological Processes in Cancer
    Yang Zhao, Marisela Sheldon, Yutong Sun, Li Ma · 2023 · Cancers
  45. Wnt/β-catenin signaling regulates follicular development by modulating the expression of Foxo3a signaling components
    Lei Li, Shaoyang Ji, Junling Yang, Xixia Li, Jun Zhang, Yang Zhang, Zhao‐Yuan Hu, Yixun Liu · 2013 · Molecular and Cellular Endocrinology
  46. Aurora A kinase activates YAP signaling in triple-negative breast cancer
    S.H. Chang, Hirohito Yamaguchi, W Xia, S-O Lim, Yekaterina B. Khotskaya, Yun Wu, W-C Chang, Qinqin Liu, Mien‐Chie Hung · 2016 · Oncogene
  47. Factors Affecting the Nuclear Localization of β‐Catenin in Normal and Malignant Tissue
    Rhys G. Morgan, Jenna Ridsdale, Alex Tonks, Richard L. Darley · 2014 · Journal of Cellular Biochemistry
  48. The dual functions of YAP-1 to promote and inhibit cell growth in human malignancy
    Hai Wang, Yu Chen Du, Xiao Jun Zhou, Hong Liu, Shou‐Ching Tang · 2013 · Cancer and Metastasis Reviews
  49. Hippo signalling in intestinal regeneration and cancer
    Alex Gregorieff, Jeffrey L. Wrana · 2017 · Current Opinion in Cell Biology
  50. Hippo‐yap signaling in ocular development and disease
    Matthew Lee, Navneet Goraya, Seonhee Kim, Seo‐Hee Cho · 2018 · Developmental Dynamics
  51. Towards a compendium of essential genes – From model organisms to synthetic lethality in cancer cells
    Tianzuo Zhan, Michael Boutros · 2015 · Critical Reviews in Biochemistry and Molecular Biology
  52. YES1 Is a Targetable Oncogene in Cancers Harboring YES1 Gene Amplification
    Natsuki Hamanaka, Yoshito Nakanishi, Takakazu Mizuno, Kana Horiguchi-Takei, Nukinori Akiyama, Hiromi Tanimura, Masami Hasegawa, Yasuko Satoh, Yukako Tachibana, Toshihiko Fujii et al. · 2019 · Cancer Research
  53. YAP‑mediated crosstalk between the Wnt and Hippo signaling pathways (Review
    Liya Jiang, Juan Li, Chenxing Zhang, Yufeng Shang, Jun Lin · 2020 · Molecular Medicine Reports
  54. YES1: A Novel Therapeutic Target and Biomarker in Cancer
    Irati Garmendia, Esther Redín, Luis M. Montuenga, Alfonso Calvo · 2022 · Molecular Cancer Therapeutics
  55. Targeting a Lipid Desaturation Enzyme, SCD1, Selectively Eliminates Colon Cancer Stem Cells through the Suppression of Wnt and NOTCH Signaling
    Yeongji Yu, Hyejin Kim, SeokGyeong Choi, Jinsuh Yu, Joo Yeon Lee, Hani Lee, Sukjoon Yoon, Woo‐Young Kim · 2021 · Cells
  56. β-Catenin-CCL2 feedback loop mediates crosstalk between cancer cells and macrophages that regulates breast cancer stem cells
    Fan Zhang, Pan Li, Shuang Liu, Mingqiang Yang, Shanshan Zeng, Junjian Deng, Danyang Chen, Yanmei Yi, Hao Liu · 2021 · Oncogene
  57. WNT/β‐catenin pathway is a key regulator of cardiac function and energetic metabolism
    Volodymyr V. Balatskyi, Adrian Sówka, Paweł Dobrzyń, Oksana O. Piven · 2023 · Acta Physiologica
  58. YAP and β-catenin cooperate to drive H. pylori -induced gastric tumorigenesis
    Nianshuang Li, Xinbo Xu, Yuan Zhan, Fei Xiao, Yaobin Ouyang, Pan Zheng, Yanan Zhou, Cong He, Chuan Xie, Yi Hu et al. · 2023 · Gut Microbes
  59. Genomic analysis and selective small molecule inhibition identifies BCL-XL as a critical survival factor in a subset of colorectal cancer
    Haichao Zhang, John Xue, Paul Hessler, Stephen K. Tahir, Jun Chen, Sha S Jin, Andrew James Souers, Joel D. Leverson, Lloyd T. Lam · 2015 · Molecular Cancer
  60. A TAZ-AXL-ABL2 Feed-Forward Signaling Axis Promotes Lung Adenocarcinoma Brain Metastasis
    Jacob P. Hoj, Benjamin Mayro, Ann Marie Pendergast · 2019 · Cell Reports
  61. Functional Screening Identifies miRNAs Influencing Apoptosis and Proliferation in Colorectal Cancer
    Lise Lotte Christensen, Anja Holm, Juha Rantala, Olli Kallioniemi, Mads Heilskov Rasmussen, Marie S. Ostenfeld, Frederik Dagnæs‐Hansen, Bodil Øster, Troels Schepeler, Heidi Tobiasen et al. · 2014 · PLoS ONE
  62. Functional roles of SRC signaling in pancreatic cancer: Recent insights provide novel therapeutic opportunities
    Ashleigh R. Poh, Matthias Ernst · 2023 · Oncogene
  63. Hippo-Independent Regulation of Yki/Yap/Taz: A Non-canonical View
    Yong Suk Cho, Jin Jiang · 2021 · Frontiers in Cell and Developmental Biology
  64. CRB3 regulates contact inhibition by activating the Hippo pathway in mammary epithelial cells
    Xiaona Mao, Pingping Li, Yaochun Wang, Zheyong Liang, Jie Liu, Juan Li, Yina Jiang, Gang Bao, Lei Li, Bofeng Zhu et al. · 2017 · Cell Death and Disease
  65. Regulation of Tissue Growth by the Mammalian Hippo Signaling Pathway
    Kevin I. Watt, Kieran F. Harvey, Paul Gregorevic · 2017 · Frontiers in Physiology
  66. A tightly controlled Src-YAP signaling axis determines therapeutic response to dasatinib in renal cell carcinoma
    Jingya Sun, Xin Wang, Boyun Tang, Hong‐Chun Liu, Minmin Zhang, Yueqin Wang, Fangfang Ping, Jian Ding, Aijun Shen, Meiyu Geng · 2018 · Theranostics
  67. Functional and genomic analyses reveal therapeutic potential of targeting β-catenin/CBP activity in head and neck cancer
    Vinay K. Kartha, Khalid A. Abalkhail, Khikmet Sadykov, Bach-Cuc Nguyen, Fabrice Laroche, Hui Feng, Jina Lee, Sara Isabel Pai, Xaralabos Varelas, Ann Marie Egloff et al. · 2018 · Genome Medicine
  68. Cadherins and catenins in cancer: connecting cancer pathways and tumor microenvironment
    Wan‐Hsin Lin, Lisa M. Cooper, Panos Z. Anastasiadis · 2023 · Frontiers in Cell and Developmental Biology
  69. The OncoPPi Portal: an integrative resource to explore and prioritize protein–protein interactions for cancer target discovery
    Andrei A. Ivanov, Brian Revennaugh, Lauren E. Rusnak, Valentina González-Pecchi, Xiulei Mo, Margaret A. Johns, Yuhong Du, Lee Cooper, Carlos S. Moreno, Fadlo Raja Khuri et al. · 2017 · Bioinformatics
  70. Overview of Three Proliferation Pathways (Wnt, Notch, and Hippo) in Intestine and Immune System and Their Role in Inflammatory Bowel Diseases (IBDs)
    Seyed Mobin Khoramjoo, Nesa Kazemifard, Shaghayegh Baradaran Ghavami, Maryam Farmani, Shabnam Shahrokh, Hamid Asadzadeh Aghdaei, Ghazal Sherkat, Mohammad Reza Zali · 2022 · Frontiers in Medicine
  71. The YAP1/SIX2 axis is required for DDX3-mediated tumor aggressiveness and cetuximab resistance in KRAS-wild-type colorectal cancer
    De‐Wei Wu, Po-Lin Lin, Lee Wang, Chi‐Chou Huang, Huei Lee · 2017 · Theranostics
  72. Emerging roles of YAP/TAZ in lung physiology and diseases
    Haojun Xie, Li-Quan Wu, Zhenan Deng, Yating Huo, Yuanxiong Cheng · 2018 · Life Sciences
  73. Meta-Analysis and Systematic Review of the Genomics of Mucosal Melanoma
    Natasa Broit, Peter A. Johansson, Chloe B. Rodgers, Sebastian Walpole, Felicity Newell, Nicholas K. Hayward, Antonia L. Pritchard · 2021 · Molecular Cancer Research
  74. Targeting the Hippo pathway in heart repair
    Fansen Meng, Bing Xie, James F. Martin · 2021 · Cardiovascular Research
  75. The Regulatory Machinery of Neurodegeneration in In Vitro Models of Amyotrophic Lateral Sclerosis
    Burcin Ikiz, Mariano J. Alvarez, Diane Bérangère Ré, Virginia Le Verche, Kristin A. Politi, Francesco Lotti, Sudarshan Phani, Radhika Pradhan, Changhao Yu, Gist F. Croft et al. · 2015 · Cell Reports
  76. Capturing the mammalian Hippo: Elucidating its role in cancer
    Miki Nishio, Kohei Otsubo, Tomohiko Maehama, Koshi Mimori, Akira Suzuki · 2013 · Cancer Science
  77. Wnt activated β-catenin and YAP proteins enhance the expression of non-coding RNA component of RNase MRP in colon cancer cells
    Jinjoo Park, Sunjoo Jeong-Yu · 2015 · Oncotarget
  78. Probing the canonicity of the Wnt/Wingless signaling pathway
    Alexandra Franz, Daria Shlyueva, Erich Brunner, Alexander Stark, Konrad Basler · 2017 · PLoS Genetics
  79. Yap1 safeguards mouse embryonic stem cells from excessive apoptosis during differentiation
    Lucy LeBlanc, Bum‐Kyu Lee, Andy C Yu, Mijeong Kim, Aparna V Kambhampati, Shannon M. Dupont, Davide Seruggia, Byoung U Ryu, Stuart H. Orkin, Jonghwan Kim · 2018 · eLife
  80. Hippo‐Yap/Taz signaling: Complex network interactions and impact in epithelial cell behavior
    Benjamin J. van Soldt, Wellington Veras Cardoso · 2019 · Wiley Interdisciplinary Reviews Developmental Biology
  81. Molecular Classification and Therapeutic Targets in Ependymoma
    Thomas Larrew, Brian Fabian Saway, Stephen R. Lowe, Adriana Olar · 2021 · Cancers
  82. Prognostic Value of Yes-Associated Protein 1 (YAP1) in Various Cancers: A Meta-Analysis
    Zhenqiang Sun, Ruiwei Xu, Xiayu Li, Weiguo Ren, Chunlin Ou, Qisan Wang, Han Zhang, Xuemei Zhang, Jian Ma, Haijiang Wang et al. · 2015 · PLoS ONE
  83. Fat4 suppression induces Yap translocation accounting for the promoted proliferation and migration of gastric cancer cells
    Liangang Ma, Jianxin Cui, Hongqing Xi, Shibo Bian, Bo Wei, Lin Chen · 2015 · Cancer Biology & Therapy
  84. Targeting loss of the Hippo signaling pathway in NF2-deficient papillary kidney cancers
    Carole Sourbier, Pei‐Jyun Liao, Christopher J. Ricketts, Darmood Wei, Youfeng Yang, Sarah M. Baranes, Benjamin K. Gibbs, Lernik Ohanjanian, Louis Spencer Krane, Bradley T. Scroggins et al. · 2018 · Oncotarget
  85. YAP-dependent ubiquitination and degradation of β-catenin mediates inhibition of Wnt signalling induced by Physalin F in colorectal cancer
    Chen Chen, Dong‐Rong Zhu, Hao Zhang, Chao Han, Gui‐Min Xue, Tianyu Zhu, Jian‐Guang Luo, Lingyi Kong · 2018 · Cell Death and Disease
  86. YAP and the Hippo pathway in cholangiocarcinoma
    Takaaki Sugihara, Hajime Isomoto, Gregory James Gores, Rory L. Smoot · 2019 · Journal of Gastroenterology
  87. Integrating Genomics Into Clinical Pediatric Oncology Using the Molecular Tumor Board at the Memorial Sloan Kettering Cancer Center
    Michael Vincent Ortiz, Rachel Kobos, Michael Francis Walsh, Emily Kanaya Slotkin, Stephen S. Roberts, Michael F. Berger, Meera Hameed, David B. Solit, Marc Ladanyi, Neerav Narendra Shukla et al. · 2016 · Pediatric Blood & Cancer
  88. The molecular rationale of Src inhibition in colorectal carcinomas
    Gargalionis, Antonios N., Karamouzis, Michalis V., Papavassiliou, Athanasios G. · 2014 · International Journal of Cancer
  89. Hippo Signaling at the Hallmarks of Cancer and Drug Resistance
    Ramesh Kumar, Wanjin Hong · 2024 · Cells
  90. MiR-497 Suppresses YAP1 and Inhibits Tumor Growth in Non-Small Cell Lung Cancer
    Chongbiao Huang, Ruijue Ma, Jie Yue, Na Li, Zengxun Li, Daliang Qi · 2015 · Cellular Physiology and Biochemistry
  91. Targeting the Hippo signalling pathway for cancer treatment
    Keisuke Nakatani, Tomohiko Maehama, Miki Nishio, Hiroki Goto, Wakako Kato, Hirofumi Omori, Yosuke Miyachi, Hideru Togashi, Yohei Shimono, Akira Suzuki · 2016 · The Journal of Biochemistry
  92. ZFP57 suppress proliferation of breast cancer cells through down-regulation of MEST-mediated Wnt/β-catenin signalling pathway
    Lie Chen, Xiaowei Wu, Hui Xie, Na Yao, Yiqin Xia, Ge Ma, Mengjia Qian, Han Ge, Yangyang Cui, Yue Huang et al. · 2019 · Cell Death and Disease
  93. Hippo Pathway and YAP Signaling Alterations in Squamous Cancer of the Head and Neck
    Karla Santos-de-Frutos, Carmen Segrelles, Corina Lorz · 2019 · Journal of Clinical Medicine
  94. YAP promotes sorafenib resistance in hepatocellular carcinoma by upregulating survivin
    Ting Sun, Wenhao Mao, Hui Peng, Qi Wang, Lin Jiao · 2021 · Cellular Oncology
  95. Subversion of Niche-Signalling Pathways in Colorectal Cancer: What Makes and Breaks the Intestinal Stem Cell
    Nathalie Sphyris, Michael C. Hodder, Owen James Sansom · 2021 · Cancers
  96. The Hippo pathway: Organ size control and beyond
    Pengfei Guo, Sicheng Wan, Kun‐Liang Guan · 2024 · Pharmacological Reviews
  97. Integration of mechanical and chemical signals by YAP and TAZ transcription coactivators
    Xiaocan Guo, Bin Zhao · 2013 · Cell & Bioscience
  98. Targeting the Hippo pathway: Clinical implications and therapeutics
    Shuai Ye, T.S. Karin Eisinger‐Mathason · 2015 · Pharmacological Research
  99. Tissue inhibitor of metalloproteinase-1 promotes cell proliferation through YAP/TAZ activation in cancer
    Toshinori Ando, Dyshafilia Charindra, Madhu Shrestha, Hanako Umehara, Ikuko Ogawa, Mutsumi Miyauchi, Takashi Takata · 2017 · Oncogene
  100. Repurposing of Drugs Targeting YAP-TEAD Functions
    Gian Marco Elisi, Matteo Santucci, Domenico D’Arca, Angela Lauriola, Gaetano Marverti, Lorena Losi, Laura Scalvini, María Laura Bolognesi, Marco Mor, Maria Paola Costi · 2018 · Cancers